FDA update

Epilepsy Research

Volumn 68, Issue 1, 2006, Pages 85-94

  Katz, Russell ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PREGABALIN; TIAGABINE; TOPIRAMATE; ZONISAMIDE;

BENIGN CHILDHOOD EPILEPSY; CONFERENCE PAPER; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; FOCAL EPILEPSY; FOOD AND DRUG ADMINISTRATION; HUMAN; MONOTHERAPY; PEDIATRICS; PRIORITY JOURNAL;

ADULT; ANTICONVULSANTS; CHILD; DRUG APPROVAL; DRUG TOXICITY; HUMANS; PEDIATRICS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 30144435757     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2005.09.034     Document Type: Conference Paper

References (3)

1. J.A. French, and S. Schachter A workshop on antiepileptic drug monotherapy indications Epilepsia 43 Suppl. 10 2002 3 27
2. R. Temple, and S. Ellenberg Placebo-controlled trials and active-control trials in the evaluation of new treatment. Part 1. Ethical and scientific issues Ann. Intern. Med. 133 2000 455 463
3. R. Temple, and S. Ellenberg Placebo-controlled trials and active-control trials in the evaluation of new treatment. Part 1. Practical issues and specific cases Ann. Intern. Med. 133 2000 464 470